340B Manufacturer Audits Ramping Up In 2015
This article was originally published in The Pink Sheet Daily
Executive Summary
HRSA has launched only one audit of a drug manufacturer for compliance with 340B drug pricing requirements, and that is still ongoing, but the agency plans additional audits in 2015.